Capital International Investors raised its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 25,843,701 shares of the healthcare conglomerate’s stock after purchasing an additional 1,082,141 shares during the quarter. UnitedHealth Group comprises about 2.6% of Capital International Investors’ investment portfolio, making the stock its 6th largest position. Capital International Investors’ holdings in UnitedHealth Group were worth $7,597,531,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Psagot Investment House Ltd. raised its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. Psagot Investment House Ltd. now owns 9,222 shares of the healthcare conglomerate’s stock valued at $2,004,000 after purchasing an additional 122 shares during the period. Colony Group LLC raised its holdings in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Colony Group LLC now owns 122,884 shares of the healthcare conglomerate’s stock valued at $26,705,000 after purchasing an additional 1,436 shares during the period. Voya Financial Advisors Inc. raised its holdings in shares of UnitedHealth Group by 5.9% in the 3rd quarter. Voya Financial Advisors Inc. now owns 35,112 shares of the healthcare conglomerate’s stock valued at $7,558,000 after purchasing an additional 1,945 shares during the period. Virtu Financial LLC raised its holdings in shares of UnitedHealth Group by 178.0% in the 3rd quarter. Virtu Financial LLC now owns 12,968 shares of the healthcare conglomerate’s stock valued at $2,818,000 after purchasing an additional 8,304 shares during the period. Finally, Highland Capital Management LLC raised its holdings in shares of UnitedHealth Group by 2.3% in the 3rd quarter. Highland Capital Management LLC now owns 34,391 shares of the healthcare conglomerate’s stock valued at $7,474,000 after purchasing an additional 786 shares during the period. Hedge funds and other institutional investors own 88.16% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of the stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total transaction of $1,060,000.00. Following the transaction, the director now owns 158,598 shares in the company, valued at approximately $33,622,776. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $306.04, for a total transaction of $3,060,400.00. Following the transaction, the director now owns 158,598 shares in the company, valued at approximately $48,537,331.92. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,000 shares of company stock worth $12,081,050. Company insiders own 0.87% of the company’s stock.
Shares of NYSE:UNH traded up $11.26 on Thursday, reaching $245.75. 2,399,157 shares of the company’s stock were exchanged, compared to its average volume of 9,053,138. The company has a fifty day moving average of $270.98 and a 200-day moving average of $265.18. UnitedHealth Group Inc has a twelve month low of $187.72 and a twelve month high of $306.71. The company has a market capitalization of $208.50 billion, a price-to-earnings ratio of 17.15, a PEG ratio of 1.04 and a beta of 0.70. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The firm had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. During the same quarter in the prior year, the business posted $3.28 EPS. The business’s revenue was up 4.3% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Inc will post 16.47 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 24th. Shareholders of record on Monday, March 16th were given a dividend of $1.08 per share. The ex-dividend date was Friday, March 13th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.76%. UnitedHealth Group’s payout ratio is presently 28.59%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Capital Gains Distribution
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.